Author:
Fricke Uwe,Schwabe Ulrich
Publisher
Springer Berlin Heidelberg
Reference106 articles.
1. Alexander C.L., Miller S.J., Abel S.R. (2002): Prostaglandin analog treatment of glaucoma and ocular hypertension. Ann. Pharmacother. 36: 504–511.
2. Ally R., Schürmann D., Kreisel W., Carosi G., Aguirrebengoa K., Dupont B. et al. and the Esophageal Candidiasis Study Group (2001): A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin. Infect. Dis. 33: 1447–1454.
3. Arato M., O’Connor R., Meltzer H.Y. and the ZEUS Study Group (2002): A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study. Int. Clin. Psychopharmacol. 17: 207–215.
4. Arzneimittelkommission der deutschen Apotheker (2002): Rote-Hand-Brief: Parecoxib (Dynastat®). Pharm. Ztg. 147: 4188.
5. Arzneimittelkommission der deutschen Apotheker (2003): Vertriebseinstellung von Nefadar. Pharm. Ztg. 148: 625–000.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antiallergika;Arzneiverordnungs-Report 2009;2009
2. Antiallergika;Arzneiverordnungs-Report 2008;2008
3. Antiallergika;Arzneiverordnungs-Report 2004;2004
4. Antiallergika;Arzneiverordnungs-Report 2007
5. Antiallergika;Arzneiverordnungs-Report 2006